Evidence map›Paper›PMID 42781526›Full record

ArticleInternational journal of pharmaceutics: X2026

In vivo comparison of enteric capsule shells composed of different HPMCAS grades after simultaneous intake by dual MRI labeling and pharmacokinetics.

Michael Grimm, Ruben Lau, Fiona Mankertz, Robin Bülow, Felix Morof, Delphine Nombret, Camille Dumont, Vincent Jannin, Mladen Vassilev Tzvetkov, Werner Weitschies

Abstract read
In one paragraph

Article in International journal of pharmaceutics: X, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Michael GrimmDepartment of Biopharmaceutics and Pharmaceutical Technology, University of Greifswald, 17489 Greifswald, Germany.
Ruben LauDepartment of Biopharmaceutics and Pharmaceutical Technology, University of Greifswald, 17489 Greifswald, Germany.
Fiona MankertzDepartment of Diagnostic Radiology and Neuroradiology, University Hospital Greifswald, 17475 Greifswald, Germany.
Robin BülowDepartment of Diagnostic Radiology and Neuroradiology, University Hospital Greifswald, 17475 Greifswald, Germany.
Felix MorofDepartment of General Pharmacology, University Hospital Greifswald, 17487 Greifswald, Germany.
Delphine NombretCapsugel France SAS, 68000 Colmar, France.
Camille DumontCapsugel France SAS, 68000 Colmar, France.
Vincent JanninCapsugel France SAS, 68000 Colmar, France.
Mladen Vassilev TzvetkovDepartment of General Pharmacology, University Hospital Greifswald, 17487 Greifswald, Germany.
Werner WeitschiesDepartment of Biopharmaceutics and Pharmaceutical Technology, University of Greifswald, 17489 Greifswald, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Different grades of hypromellose acetate succinate (HPMCAS) differ in their pH dependent dissolution behavior, which is of key relevance when used for enteric coating or gastroresistant capsule shells. By use of specific grades it could be possible to tailor intestinal release in terms of timing and localization. A crossover design might be the gold standard for comparison of two dosage forms but intraindividual variability in gastrointestinal transit conditions still limit robust comparability. In the present study, two prototype capsule shells made of HPMCAS grade L and M, were compared with reference Capsugel® Enprotect® capsules made of grade H. For avoidance of intraindividual variability affecting the comparison of two dosage forms with a limited group of subjects, an approach with an internal standard should be used. Thus, reference capsules and the two types of test capsules were administered by healthy young volunteers in fasted state in a 2-arm crossover study. Test capsule and reference capsule were always administered together allowing for an internal reference. To enable differentiation in magnetic resonance imaging (MRI), the reference and test capsules contained different amounts of black iron oxide. The test capsules additionally contained manganese gluconate. The capsules also contained different types of

Indexed as

CaffeineDual labelingEnteric hard capsuleHydroxypropyl methyl cellulose acetate succinate (HPMCAS) gradesIntraindividual variabilityMagnetic resonance imaging (MRI)Manganese gluconateSalivaStable isotope

Identifiers

PMID42781526
PMCPMC13599660

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.